Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LY3321367 |
Trade Name | |
Synonyms | LY 3321367|LY-3321367 |
Drug Descriptions |
LY3321367, is monoclonal antibody that targets T-cell immunoglobulin and mucin domain-3 protein (TIM-3, HAVCR2), potentially resulting in enhanced anti-tumor immune response (NCI Drug Dictionary). |
DrugClasses | Immune Checkpoint Inhibitor 149 TIM-3 Antibody 9 |
CAS Registry Number | NA |
NCIT ID | C137820 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LY3300054 + LY3321367 | LY3300054 LY3321367 | 0 | 1 |
LY3321367 | LY3321367 | 0 | 1 |